Keywords: Russia, Colorectal cancer, Market forecast, Decision Resources

Russia's colorectal cancer drug market to reach over $480 million in 2016

Article | 31 May 2012

The colorectal cancer (CRC) drug market in Russia will grow 3% annually to $487 million in 2016, according to a new report from ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in